The impact of curative conversion therapy aimed at a cancer‐free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
暂无分享,去创建一个
T. Kawaguchi | H. Koga | Masatoshi Tanaka | S. Shimose | H. Iwamoto | R. Kuromatsu | Y. Yano | T. Niizeki | T. Shirono | M. Nakano | Y. Noda | S. Itano | M. Kajiwara | Etsuko Moriyama | Satoru Matsugaki